Concepedia

Emily Robitschek

ER

5

Publications

1.3K

Citations

5

H-Index

2018

Active since

Affiliations

Broad Institute(Current)

Dana-Farber Cancer Institute

Massachusetts Institute of Technology

Harvard University

Massachusetts General Hospital

Emily Robitschek is an author at Broad Institute specializing in immunology, tumor microenvironment, and medicine.

ORCID

Top concepts

Publications per year

2018–2024

5

Publications

5

Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade

Jeffrey J. Ishizuka, Robert T. Manguso, Collins Cheruiyot et al. · Nature · 2018 · 688 citations · Full text

, , +8

Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity

Gabriel K. Griffin, Jingyi Wu, Arvin Iracheta‐Vellve et al. · Nature · 2021 · 339 citations · Full text

, , +6

Targeting TBK1 to overcome resistance to cancer immunotherapy

Yi Sun, Or‐Yam Revach, Seth Anderson et al. · Nature · 2023 · 156 citations · Full text

, , +5

Evolution of delayed resistance to immunotherapy in a melanoma responder

David Liu, Jia‐Ren Lin, Emily Robitschek et al. · Nature Medicine · 2021 · 117 citations · Full text

, , +9

Targeting the aminopeptidase ERAP enhances antitumor immunity by disrupting the NKG2A-HLA-E inhibitory checkpoint

Hsiao‐Wei Tsao, Seth Anderson, Kenneth J. Finn et al. · Immunity · 2024 · 14 citations · Full text

Rows per page

1–5 of 5